Susan Coller Monarez, Ph.D., is Founder and CEO of Heartland Global Strategies, where she advises governments, academic institutions, and technology innovators on translating emerging science, including artificial intelligence and advanced analytics, into stronger health systems and improved global health outcomes. A scientist and senior leader in biomedical innovation, she has spent more than three decades advancing science, technology, and health policy across government and international partnerships.
Dr. Monarez most recently served as the first Senate Confirmed Director of the Centers for Disease Control and Prevention and previously as Deputy Director of the Advanced Research Projects Agency for Health (ARPA-H), where she helped launch a national research initiative designed to accelerate transformative biomedical technologies. Earlier in her career, she served as a biomedical and emerging technology advisor at the White House on both the National Security Council and the Office of Science and Technology Policy.
Dr. Monarez has also advised U.S. and international institutions including the National Academy of Medicine, the World Health Organization, the European Commission, and the Organisation for Economic Co-operation and Development on emerging biomedical technologies and research governance. She is a TIME100 and Nature 10 honoree.
